Riskpilot← Back to searchSign inGet full accessJÆRGYNEKOLOGANE AS
ASActiveOrg 817784542Arne Garborgs Veg 15, 4344 BryneMedical specialists activities · NACE 8622Est. 20165 employees
Revenue 2024
NOK 2,3M
0% vs 2023
EBITDA margin
0.5%
-32% vs 2023
Equity ratio
53.9%
Financial strength
Net profit 2024
NOK 2K
-83% vs 2023
| Revenue | NOK 2,3M | +0% |
| EBITDA | NOK 12K | -32% |
| Net profit | NOK 2K | -83% |
| Total assets | NOK 603K | -6% |
| Equity | NOK 325K | +1% |
| Employees | 5 | — |
Legal name
JÆRGYNEKOLOGANE AS
Org number
817784542
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
27. september 2016
Share capital
NOK 200 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av gynekologkontor, stille utstyr og personell til rådighet for egne gynekologer, samt gynekologer som er tilknyttet senteret. Handel, hva dermed står i forbindelse, samt deltakelse i andre selskaper med lignende formål.
Address
Arne Garborgs Veg 15, 4344 Bryne
Phone
+4751778090
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 195 | 2 409 | 2 318 | 2 310 | 2 310 |
| Staff expenses | −1 247 | −1 368 | −1 252 | −1 293 | −1 259 |
| EBITDA | 87 | 88 | 30 | 18 | 12 |
| Depreciation & amort. | −82 | −82 | −29 | −3 | −10 |
| EBIT | 5 | 6 | 1 | 15 | 2 |
| Net financials | −2 | −4 | 1 | 1 | 1 |
| Profit before tax | 3 | 2 | 2 | 16 | 3 |
| Tax | 1 | 0 | 1 | 3 | 1 |
| Net profit | 2 | 2 | 2 | 12 | 2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 828 | 609 | 570 | 642 | 603 |
| Equity | 308 | 309 | 311 | 323 | 325 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 521 | 300 | 259 | 319 | 278 |
| Total debt | 521 | 300 | 259 | 319 | 278 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20202024
Equity ratio
53.9%
This company
38.2%
Market median
+41% vs market
20202024
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
3.83×
This company
1.12×
Market median
+242% vs market
20202024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TV Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JÆRGYNEKOLOGANE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tonje Vaula | Chief Executive Officer | 0 companies |
| Tone Tjørnhom | Chairman | 0 companies |